2005-05-04 - Female - 36 Years old
171024
| Adverse reaction report number | 171024 |
| Latest AER version number | 0 |
| Market authorization holder AER number | SUS1200500341 |
| Initial received date | 2005-05-04 |
| Latest received date | 2005-05-04 |
| Age | 36 Years |
| Gender | Female |
| Weight | N/A |
| Type of report | Spontaneous |
| Reporter type | Consumer Or Other Non Health Professional |
| Source of report | Community |
| Report outcome | Recovered/resolved |
| Serious report? | Yes |
Reason for seriousness
| Death | |
| Disability | |
| Cogenital anomaly | |
| Life threateting | |
| Hospitalization | |
| Other medically important | Yes |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | 140 Milligram | every 1 Day(s) | 1 Year(s) | ||
| TRAZODONE | TABLET | Concomitant | |||||
| BENADRYL | NOT SPECIFIED | Drug used to treat AE |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Accidental overdose | |
| Anxiety | |
| Exophthalmos | |
| Rash | |
| Swollen tongue | |
| Throat tightness | |